Bioequivalence of Amphotericin B Liposome for Injection

Condition:   Bioequivalence Interventions:   Drug: Amphotericin B liposome for injection;   Drug: AmBisome Sponsor:   CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Active, not recruiting

Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials